AllianceBernstein’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History

AllianceBernstein’s Portfolio ELOX Stock Details ELOX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-528	Closed	-$70K	–	3482
2021 Q1	$70K	Sell	528 -50	-9%	-$7.64K	﹤0.01%	3183
2020 Q4	$92K	Hold	578	–	–	﹤0.01%	3111
2020 Q3	$61K	Sell	578 -50	-8%	-$5.99K	﹤0.01%	3112
2020 Q2	$76K	Buy	628 +93	+17%	+$10.5K	﹤0.01%	3129
2020 Q1	$42K	Buy	535 +35	+7%	+$5.7K	﹤0.01%	3069
2019 Q4	$147K	Hold	500	–	–	﹤0.01%	2983
2019 Q3	$90K	Buy	500 +67	+15%	+$19.1K	﹤0.01%	3095
2019 Q2	$172K	Buy	433 +108	+33%	+$45.5K	﹤0.01%	3001
2019 Q1	$152K	Buy	+325	New	+$158K	﹤0.01%	2959

Other funds holding ELOX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

AFG

American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return

Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return

ACM

Altium Capital Management New York $42M AUM

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

AllianceBernstein's ELOX Position: Q2 2021 in Review

AllianceBernstein sold out of Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) in Q2 2021, closing a stake of 528 shares — an estimated $70K sold.

AllianceBernstein first reported a position in ELOX in Q1 2019 and held it in 9 quarters. The position peaked at $172K in Q2 2019. 46 funds tracked by Wall St. Rank hold ELOX as of Q2 2021.

AllianceBernstein reported no remaining Eloxx Pharmaceuticals, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
AllianceBernstein sold 528 Eloxx Pharmaceuticals, Inc. Common Stock shares in Q2 2021, an estimated $70K.
AllianceBernstein first reported a position in Eloxx Pharmaceuticals, Inc. Common Stock in Q1 2019 and held it in 9 quarters.
AllianceBernstein's Eloxx Pharmaceuticals, Inc. Common Stock position peaked at $172K in Q2 2019.
46 funds tracked by Wall St. Rank held Eloxx Pharmaceuticals, Inc. Common Stock as of Q2 2021.

Based on AllianceBernstein's 13F filing for Q2 2021, filed 30 Jul 2021.